Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 EXCO Technologies Ltd. 3XT Apr 25, 2025 3.52 +1.15   
 Exedy Corporation 64M Apr 25, 2025 24.80 +3.33   
 EXEL COMPOSITES OYJ 8TY Apr 25, 2025 0.35 +0.86   
 Exel Industries 8YK Apr 25, 2025 34.20 -1.44   
 Exelixis, Inc. EX9 Apr 25, 2025 32.61 +3.00   
 Exelon Corporation PEO Apr 25, 2025 40.70 -0.51   
 ExlService Holdings, Inc. LHV Apr 25, 2025 39.46 -1.42   
 Exmar NV 1EX Apr 25, 2025 11.32 -1.74   
 Exor N.V. EYX Apr 25, 2025 82.75 +5.21   
 EXOSENS EO -,425 H8Y Apr 25, 2025 34.75 +4.20   
 eXp World Holdings, Inc. 44Y Apr 25, 2025 7.90 +0.10   
 Expedia Group, Inc. E3X1 Apr 25, 2025 139.60 +4.16   
 Expeditors International of Washington, Inc. EW1 Apr 25, 2025 96.28 +6.20   
 Experian PLC J2B Apr 25, 2025 42.20 +4.98   
 Experian Plc J2BA Apr 25, 2025 42.00 +5.00   
 EXPERT SYSTEM S P A AZIONI ORDINARIE SENZA VALORE (NOMINALE 3K2 Apr 25, 2025 1.25 -1.73   
 Exploits Discovery Corp 634 Apr 25, 2025 0.01 +2 400.00   
 Exponent, Inc. EP5 Apr 25, 2025 69.12 +0.35   
 ExpreS2ion Biotech Holding 5JD0 Apr 25, 2025 1.77 +2.31   
 Exro Technologies Inc 1O2 Apr 25, 2025 0.07 +122.22   
 Exsitec 1TI Apr 25, 2025 11.00 +18.53   
 Extendicare Inc 5XE Apr 25, 2025 8.40 +1.20   
 Extra Space Storage Inc. FG8 Apr 25, 2025 123.60 +0.04   
 Extreme Networks, Inc. EXM Apr 25, 2025 10.66 +6.38   
 Exxaro Resources Ltd LCQ Apr 25, 2025 7.10 +2.90   
 EXXON MOBIL CDR REG.S XON Apr 25, 2025 12.40 +3.87   
 Exxon Mobil Corporation XONA Apr 25, 2025 95.62 +0.97   
 EyePoint Pharmaceuticals, Inc. PV3B Apr 25, 2025 5.71 +16.85   
 Ezaki Glico Co. Ltd. 5EJ Apr 25, 2025 28.00 -0.71   
 EZCORP, Inc. - Class A Non-Voting EZ2A Apr 25, 2025 14.40 +3.60   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.